Skip to content
HowShorted

Candel Therapeutics, Inc. short interest in 2023

In 2023, Candel Therapeutics, Inc.'s disclosed short interest ran from 0.10% of shares outstanding on 13 Jan 2023 to 0.13% on 30 Nov 2023, a change of +0.03 percentage points. The year's high was 0.60% on 31 Jul 2023 and its low 0.08% on 31 Jan 2023, averaging 0.34% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.87 days on 15 Aug 2023. Full history: Candel Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Candel Therapeutics, Inc. in 2023

2023 in figures

Start of year
0.10% (13 Jan 2023)
End of year
0.13% (30 Nov 2023)
Change
+0.03 pp
High
0.60% (31 Jul 2023)
Low
0.08% (31 Jan 2023)
Average
0.34%
Highest days to cover
19.87 (15 Aug 2023)
SEC filings marked
8

Every report in 2023

Candel Therapeutics, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.10%1.00
31 Jan 20230.08%1.00
15 Feb 20230.10%1.37
28 Feb 20230.10%2.17
15 Mar 20230.14%2.45
31 Mar 20230.18%3.2110-K filed, results (8-K)
14 Apr 20230.18%6.46
31 May 20230.43%7.8510-Q filed, results (8-K)
15 Jun 20230.47%6.69
30 Jun 20230.57%5.19
14 Jul 20230.55%10.09
31 Jul 20230.60%8.24
15 Aug 20230.56%19.8710-Q filed, results (8-K)
31 Aug 20230.57%8.67
15 Sep 20230.55%15.54
29 Sep 20230.56%4.44
13 Oct 20230.55%8.26
31 Oct 20230.24%2.33
15 Nov 20230.14%1.0010-Q filed, results (8-K)
30 Nov 20230.13%1.66

See also: Candel Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.